Varaico: Literature-Extracted Genetic Variants

Gene:SLC6A8
Variant:p.G561R
Back to variants list

SLC6A8

NM_005629.4:p.G561R

Associated Papers

Effects of SLC6A8 mutation-induced creatine deficiency on cellular function in fibroblasts.

Ito S et al.

Scientific Reports, 2025

ProteoMutaMetrics: machine learning approaches for solute carrier family 6 mutation pathogenicity prediction.

Huang J et al.

Rsc Advances, 2024

Experimental and Computational Analysis of Newly Identified Pathogenic Mutations in the Creatine Transporter SLC6A8.

Ferrada E et al.

Journal of Molecular Biology, 2024

Molecular Mechanism of SLC6A8 Dysfunction with c.1699T > C (p.S567P) Mutation in Cerebral Creatine Deficiency Syndromes.

Jomura R et al.

Biological & Pharmaceutical Bulletin, 2024

Rare disease variant curation from literature: assessing gaps with creatine transport deficiency in focus.

Lyons EL et al.

Bmc Genomics, 2023

37587458 (PubMed )
Supplement: 12864_2023_9561_MOESM1_ESM.xlsx › CuratedVariants

Autism spectrum disorder in patients with inherited metabolic disorders-a large sample from a tertiary center.

Yoldaş TÇ et al.

The Turkish Journal of Pediatrics, 2021

Cyclocreatine Transport by SLC6A8, the Creatine Transporter, in HEK293 Cells, a Human Blood-Brain Barrier Model Cell, and CCDSs Patient-Derived Fibroblasts.

Uemura T et al.

Pharmaceutical Research, 2020

The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome.

Farr CV et al.

Frontiers in Synaptic Neuroscience, 2020

Rescue by 4-phenylbutyrate of several misfolded creatine transporter-1 variants linked to the creatine transporter deficiency syndrome.

El-Kasaby A et al.

Neuropharmacology, 2019

[Elucidation of Disease Mechanisms Based on Transport Function at Tissue Barriers and Challenges in Drug Development].

Ito S

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan, 2019

SLC6 Transporter Folding Diseases and Pharmacochaperoning.

Freissmuth M et al.

Handbook of Experimental Pharmacology, 2018

Abnormal N-Glycosylation of a Novel Missense Creatine Transporter Mutant, G561R, Associated with Cerebral Creatine Deficiency Syndromes Alters Transporter Activity and Localization.

Uemura T et al.

Biological & Pharmaceutical Bulletin, 2017

Urine screening for patients with developmental disabilities detected a patient with creatine transporter deficiency due to a novel missense mutation in SLC6A8.

Kato H et al.

Brain & Development, 2014

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."